May I measure the CD107a marker on NK cells derived from patients treated with immunotherapy directly without in vitro stimulation with target cells or interleukins? I suppose that expression of CD107a was stimulated by immunotherapy in patient blood, and it does not require another stimulation. Am I right?
Thank you in advance!